SCHEMBL9944273

SCHEMBL9944273

CC/C(=N\N1CCOCC1)C(C)(C)C

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.37
TSHR P16473 2/20 0.35
MAPT P10636 4/20 0.34
SMN1; SMN2 Q16637 4/20 0.33
ALDH1A1 P00352 4/20 0.33
RAB9A P51151 2/20 0.33
NPC1 O15118 1/20 0.33
RECQL P46063 2/20 0.33
CYP1A1 P04798 1/20 0.32
HTT P42858 1/20 0.32
POLB P06746 2/20 0.31
HPGD P15428 2/20 0.31
LMNA P02545 2/20 0.31
KMT2A Q03164 2/20 0.31
NPSR1 Q6W5P4 1/20 0.31
GAA P10253 2/20 0.31
MEN1 O00255 1/20 0.31
USP2 O75604 1/20 0.31
PKM P14618 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15865997 0.77 TSHR (0.41) KDM4ETSHRMAPTSMN1; SMN2ALDH1A1
SCHEMBL14276072 0.69 SMN1; SMN2 (0.42) KDM4ETSHRMAPTSMN1; SMN2ALDH1A1
SCHEMBL14000831 0.69 SMN1; SMN2 (0.42) KDM4ETSHRMAPTSMN1; SMN2ALDH1A1
SCHEMBL951889 0.64 TSHR (0.46) KDM4ETSHRMAPTSMN1; SMN2ALDH1A1
SCHEMBL9371358 0.63 ATM (0.50) TSHRMAPTSMN1; SMN2ALDH1A1RAB9A
SCHEMBL180006 0.63
SCHEMBL7229299 0.61 SMN1; SMN2 (0.37) KDM4ETSHRMAPTSMN1; SMN2ALDH1A1
SCHEMBL22882612 0.61 MAPT (0.40) KDM4ETSHRMAPTSMN1; SMN2ALDH1A1
Hydrochloric Acid SCHEMBL27505322 0.61 LMNA (0.40) KDM4EMAPTSMN1; SMN2ALDH1A1CYP1A1
SCHEMBL17393247 0.61 SMN1; SMN2 (0.50) TSHRSMN1; SMN2ALDH1A1RECQLHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8772290-B2 Alpha-arylmethoxyacrylate derivative, preparation method thereof, and pharmaceutical composition containing same Oscotech Inc. (KR) 2014-07-08 US disclosed
US-20120149707-A1 ALPHA-ARYLMETHOXYACRYLATE DERIVATIVE, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME OSCOTEC INC. (KR) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149707-A1 ALPHA-ARYLMETHOXYACRYLATE DERIVATIVE, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME HIF1A, HIF1AN, EGLN3 KDM4E 533/4885TSHR 3700/4885MAPT 1453/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.